Key facts
| Price (PPV) | 306 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | amlodipinevalsartan |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09DB01 |
| Manufacturer | AFRIC-PHAR |
| Presentation | Boite de 56 |
| Nature | Médicament |
| Hospital price | 204 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement de l'hypertension artérielle essentielle. L’association amlodipine-valsartan est indiquée chez les patients dont la tension artérielle est insuffisamment contrôlée par le valsartan seul ou par l'amlodipine seule. L’association amlodipine-valsartan est indiquée pour le traitement initial de l'hypertension artérielle. La décision de prescrire L’association amlodipine-valsartan en traitement initial de l'hypertension artérielle doit reposer sur une évaluation des bénéfices et des risques potentiels.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Suliat 10 mg / 160 mg (AFRIC-PHAR) contains the same active substance as Suliat 10 mg / 160 mg (Amlodipine | valsartan) at the same strength, but in a different pack: Boite de 14 at 105.20 MAD, i.e. 7.51 MAD per unit against 5.46 MAD for Suliat 10 mg / 160 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Suliat 10 mg / 160 mg | AFRIC-PHAR | Boite de 14 | 105.20 MAD | 7.51 / unit |
| Valmep 10 mg / 160 mg | COOPER PHARMA | Boite de 30 | 164.60 MAD | 5.49 / unit |
| Suliat 10 mg / 160 mg | AFRIC-PHAR | Boite de 28 | 185.20 MAD | 6.61 / unit |
| Xilam 10 mg / 160 mg | SOTHEMA | Boite de 28 | 185.20 MAD | 6.61 / unit |
| Lotevan 10 mg / 160 mg | ZENITH PHARMA | Boite de 30 | 198.20 MAD | 6.61 / unit |
| Exforge 10 mg / 160 mg | NOVARTIS PHARMA MAROC | Boîte de 28 | 247 MAD | 8.82 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Suliat 10 mg / 160 mg
Suliat 10 mg / 160 mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by AFRIC-PHAR and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Suliat 10 mg / 160 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Suliat 10 mg / 160 mg
Answers to common questions from Moroccan patients about this drug.